EC Status and Availability


EC ever use among women of reproductive age: 0.5% (DHS 2008-09)

EC knowledge among women of reproductive age: 10.1% (DHS 2008-09)

Contraceptive Use: 40.8% (DHS 2008-09, ever use of a modern method among women of reproductive age)

Registered LNG-EC products:

  • NorLevo 1.5mg* - Available only with prescription
  • Pill 72* - Available only with prescription
  • Pregnon - Available only with prescription
  • Revoke 72* - Available only with prescription

Registered UPA-EC products:

  • ellaOne* - Available directly from pharmacist without prescription (i.e. BTC)

Products marked with * have been approved by a stringent regulatory authority, such as the WHO Prequalification Programme, the US Food and Drug Administration, the European Medicines Agency, or other.

Where at least one type of ECP is available: Public sector clinics, Pharmacies, IPPF-affiliated system

Age restrictions for accessing ECPs: No data available

Legal/regulatory documents in which EC is included: No data available

Other relevant information: Madagascar's Essential Medicines List does not include EC.

EC distributed via IPPF outlets (<500 in 2012).

In Madagascar, the lowest cadre of health workers allowed to sell/dispense ECPs in the public sector is midwives. The lowest cadre of health workers allowed to sell/dispense ECPs in the private sector is midwives. (Data as of 2013.) (USAID/DELIVER, Contraceptive Security Indicators, 2013)

In 2013, EC was procured by the government. No stock-outs were reported at the central level (JSI/Deliver data).

Our country-by-country information comes from numerous sources, including partners from around the world. We have made every effort to ensure that the information included here is correct, but EC availability and policies can change quickly. We welcome your additions and/or corrections

To submit updates and corrections to ICEC, click here.

Begin a new search